| 1 |
33039659 | Dexmedetomidine attenuates sepsis-associated inflammation and encephalopathy via central α2A adrenoceptor. | 2021 Jan |
2 |
| 2 |
34884552 | Dexmedetomidine Promotes Lipopolysaccharide-Induced Differentiation of Cardiac Fibroblasts and Collagen I/III Synthesis through α2A Adrenoreceptor-Mediated Activation of the PKC-p38-Smad2/3 Signaling Pathway in Mice. | 2021 Nov 25 |
1 |
| 3 |
29729264 | Dexmedetomidine attenuates renal fibrosis via α2-adrenergic receptor-dependent inhibition of cellular senescence after renal ischemia/reperfusion. | 2018 Aug 15 |
2 |
| 4 |
25655994 | Alpha-2 agonist attenuates ischemic injury in spinal cord neurons. | 2015 May 1 |
1 |
| 5 |
26086861 | Contribution of α2A-adrenoceptor subtype to effect of dexmedetomidine and xylazine on spinal synaptic transmission of mice. | 2015 Aug 15 |
3 |
| 6 |
23850057 | Interruption of spinal cord microglial signaling by alpha-2 agonist dexmedetomidine in a murine model of delayed paraplegia. | 2014 Apr |
1 |
| 7 |
24035379 | Dexmedetomidine, an α-2a adrenergic agonist, promotes ischemic tolerance in a murine model of spinal cord ischemia-reperfusion. | 2014 Jan |
4 |
| 8 |
22832266 | Attenuation of spinal cord ischemia-reperfusion injury by specific α-2a receptor activation with dexmedetomidine. | 2012 Nov |
7 |
| 9 |
21054403 | Systemic daily morphine enhances the analgesic effect of intrathecal dexmedetomidine via up-regulation of alpha 2 adrenergic receptor subtypes A, B and C in dorsal root ganglion and dorsal horn. | 2010 Dec |
1 |
| 10 |
16428542 | The effects of dexmedetomidine on perinatal excitotoxic brain injury are mediated by the alpha2A-adrenoceptor subtype. | 2006 Feb |
1 |
| 11 |
15039766 | Alpha2A-adrenoceptors are important modulators of the effects of D-amphetamine on startle reactivity and brain monoamines. | 2004 Jul |
3 |
| 12 |
15464093 | Dexmedetomidine produces its neuroprotective effect via the alpha 2A-adrenoceptor subtype. | 2004 Oct 11 |
5 |
| 13 |
12726820 | Alpha2-adrenergic drug effects on brain monoamines, locomotion, and body temperature are largely abolished in mice lacking the alpha2A-adrenoceptor subtype. | 2003 Jun |
1 |
| 14 |
12081658 | In vivo regulation of dopamine and noradrenaline release by alpha2A-adrenoceptors in the mouse prefrontal cortex. | 2002 Jun |
1 |
| 15 |
11309255 | Contribution of alpha(2) receptor subtypes to nerve injury-induced pain and its regulation by dexmedetomidine. | 2001 Apr |
4 |
| 16 |
10930558 | Receptor subtype and dose dependence of dexmedetomidine-induced accumulation of [14C]glutamine in astrocytes suggests glial involvement in its hypnotic-sedative and anesthetic-sparing effects. | 2000 Aug 11 |
1 |
| 17 |
9605427 | Ligand efficacy and potency at recombinant alpha2 adrenergic receptors: agonist-mediated [35S]GTPgammaS binding. | 1998 Apr 1 |
1 |
| 18 |
9692731 | D-amphetamine and L-5-hydroxytryptophan-induced behaviours in mice with genetically-altered expression of the alpha2C-adrenergic receptor subtype. | 1998 Oct |
1 |
| 19 |
9421280 | Assessment of the role of alpha2-adrenoceptor subtypes in the antinociceptive, sedative and hypothermic action of dexmedetomidine in transgenic mice. | 1997 Dec |
4 |